EMBO REP 润色咨询

EMBO REPORTS

出版年份:2000 年文章数:2682 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:0.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2106904, encodeId=8a7121069042d, content=偏重的研究方向:干细胞<br>经验分享:哈哈,大家都不要投了,2022年最新版中科院分区该杂志已被踢出一区,指挥棒威武霸气!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b4a2455253, createdName=看看叫啥呢, createdTime=Wed Dec 21 10:37:31 CST 2022, time=2022-12-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=563739, encodeId=d8c4563e3997, content=请教EMBO reports文稿提交后多久可以收到提交成功的邮件,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Nov 28 16:43:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166320, encodeId=bc0f216632088, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:有幸中过一篇 虽然IF不高 但是杂志质量很不错的 审稿很严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d566480437, createdName=ms2000001424864644, createdTime=Thu Nov 02 16:59:11 CST 2023, time=2023-11-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119273, encodeId=f2f921192e385, content=最近有投这个期刊的老师们,请问一下初审一般要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Mon Mar 13 22:08:52 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2095960, encodeId=7b3e209596012, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:EMBO reports现任主编是Bernd Pulverer教授,之前是Nature cell biology的主编,杂志偏向于有conceptual advance的文章,从投稿到接收平均8个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue Oct 25 07:07:05 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217211, encodeId=9505121e2110c, content=怎么收不到decision letter,问编辑也不回信,怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14c65506441, createdName=ms7000001136469102, createdTime=Thu May 05 23:18:57 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964782, encodeId=015b964e8253, content=Under Editorial Consideration11th May 21 Manuscript Under Peer Review28th Apr 21 Under Editorial Consideration28th Apr 21 Manuscript Received22nd Apr 21 Manuscript Submitted21st Apr 21 这是最近投稿文章状态,可以参考一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed May 12 06:26:51 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089979, encodeId=14e010899e9b6, content=我能直接投nature/science这种顶级杂志吗?它们会反馈意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089980, encodeId=61d71089980a2, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070657, encodeId=149b10e0657ae, content=偏重的研究方向:肿瘤;干细胞<br>经验分享:还可以,embo j退稿的回收站,到elife 差远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=复旦生科院呵呵, createdTime=Tue Nov 16 08:59:39 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2022-12-21 看看叫啥呢 来自山东省

    偏重的研究方向:干细胞
    经验分享:哈哈,大家都不要投了,2022年最新版中科院分区该杂志已被踢出一区,指挥棒威武霸气!

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2106904, encodeId=8a7121069042d, content=偏重的研究方向:干细胞<br>经验分享:哈哈,大家都不要投了,2022年最新版中科院分区该杂志已被踢出一区,指挥棒威武霸气!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b4a2455253, createdName=看看叫啥呢, createdTime=Wed Dec 21 10:37:31 CST 2022, time=2022-12-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=563739, encodeId=d8c4563e3997, content=请教EMBO reports文稿提交后多久可以收到提交成功的邮件,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Nov 28 16:43:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166320, encodeId=bc0f216632088, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:有幸中过一篇 虽然IF不高 但是杂志质量很不错的 审稿很严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d566480437, createdName=ms2000001424864644, createdTime=Thu Nov 02 16:59:11 CST 2023, time=2023-11-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119273, encodeId=f2f921192e385, content=最近有投这个期刊的老师们,请问一下初审一般要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Mon Mar 13 22:08:52 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2095960, encodeId=7b3e209596012, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:EMBO reports现任主编是Bernd Pulverer教授,之前是Nature cell biology的主编,杂志偏向于有conceptual advance的文章,从投稿到接收平均8个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue Oct 25 07:07:05 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217211, encodeId=9505121e2110c, content=怎么收不到decision letter,问编辑也不回信,怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14c65506441, createdName=ms7000001136469102, createdTime=Thu May 05 23:18:57 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964782, encodeId=015b964e8253, content=Under Editorial Consideration11th May 21 Manuscript Under Peer Review28th Apr 21 Under Editorial Consideration28th Apr 21 Manuscript Received22nd Apr 21 Manuscript Submitted21st Apr 21 这是最近投稿文章状态,可以参考一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed May 12 06:26:51 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089979, encodeId=14e010899e9b6, content=我能直接投nature/science这种顶级杂志吗?它们会反馈意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089980, encodeId=61d71089980a2, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070657, encodeId=149b10e0657ae, content=偏重的研究方向:肿瘤;干细胞<br>经验分享:还可以,embo j退稿的回收站,到elife 差远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=复旦生科院呵呵, createdTime=Tue Nov 16 08:59:39 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2018-11-28 zxn2011jida

    请教EMBO reports文稿提交后多久可以收到提交成功的邮件,谢谢。

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2106904, encodeId=8a7121069042d, content=偏重的研究方向:干细胞<br>经验分享:哈哈,大家都不要投了,2022年最新版中科院分区该杂志已被踢出一区,指挥棒威武霸气!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b4a2455253, createdName=看看叫啥呢, createdTime=Wed Dec 21 10:37:31 CST 2022, time=2022-12-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=563739, encodeId=d8c4563e3997, content=请教EMBO reports文稿提交后多久可以收到提交成功的邮件,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Nov 28 16:43:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166320, encodeId=bc0f216632088, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:有幸中过一篇 虽然IF不高 但是杂志质量很不错的 审稿很严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d566480437, createdName=ms2000001424864644, createdTime=Thu Nov 02 16:59:11 CST 2023, time=2023-11-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119273, encodeId=f2f921192e385, content=最近有投这个期刊的老师们,请问一下初审一般要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Mon Mar 13 22:08:52 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2095960, encodeId=7b3e209596012, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:EMBO reports现任主编是Bernd Pulverer教授,之前是Nature cell biology的主编,杂志偏向于有conceptual advance的文章,从投稿到接收平均8个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue Oct 25 07:07:05 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217211, encodeId=9505121e2110c, content=怎么收不到decision letter,问编辑也不回信,怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14c65506441, createdName=ms7000001136469102, createdTime=Thu May 05 23:18:57 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964782, encodeId=015b964e8253, content=Under Editorial Consideration11th May 21 Manuscript Under Peer Review28th Apr 21 Under Editorial Consideration28th Apr 21 Manuscript Received22nd Apr 21 Manuscript Submitted21st Apr 21 这是最近投稿文章状态,可以参考一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed May 12 06:26:51 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089979, encodeId=14e010899e9b6, content=我能直接投nature/science这种顶级杂志吗?它们会反馈意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089980, encodeId=61d71089980a2, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070657, encodeId=149b10e0657ae, content=偏重的研究方向:肿瘤;干细胞<br>经验分享:还可以,embo j退稿的回收站,到elife 差远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=复旦生科院呵呵, createdTime=Tue Nov 16 08:59:39 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2023-11-02 ms2000001424864644 来自北京

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享:有幸中过一篇 虽然IF不高 但是杂志质量很不错的 审稿很严格

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2106904, encodeId=8a7121069042d, content=偏重的研究方向:干细胞<br>经验分享:哈哈,大家都不要投了,2022年最新版中科院分区该杂志已被踢出一区,指挥棒威武霸气!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b4a2455253, createdName=看看叫啥呢, createdTime=Wed Dec 21 10:37:31 CST 2022, time=2022-12-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=563739, encodeId=d8c4563e3997, content=请教EMBO reports文稿提交后多久可以收到提交成功的邮件,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Nov 28 16:43:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166320, encodeId=bc0f216632088, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:有幸中过一篇 虽然IF不高 但是杂志质量很不错的 审稿很严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d566480437, createdName=ms2000001424864644, createdTime=Thu Nov 02 16:59:11 CST 2023, time=2023-11-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119273, encodeId=f2f921192e385, content=最近有投这个期刊的老师们,请问一下初审一般要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Mon Mar 13 22:08:52 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2095960, encodeId=7b3e209596012, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:EMBO reports现任主编是Bernd Pulverer教授,之前是Nature cell biology的主编,杂志偏向于有conceptual advance的文章,从投稿到接收平均8个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue Oct 25 07:07:05 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217211, encodeId=9505121e2110c, content=怎么收不到decision letter,问编辑也不回信,怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14c65506441, createdName=ms7000001136469102, createdTime=Thu May 05 23:18:57 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964782, encodeId=015b964e8253, content=Under Editorial Consideration11th May 21 Manuscript Under Peer Review28th Apr 21 Under Editorial Consideration28th Apr 21 Manuscript Received22nd Apr 21 Manuscript Submitted21st Apr 21 这是最近投稿文章状态,可以参考一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed May 12 06:26:51 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089979, encodeId=14e010899e9b6, content=我能直接投nature/science这种顶级杂志吗?它们会反馈意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089980, encodeId=61d71089980a2, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070657, encodeId=149b10e0657ae, content=偏重的研究方向:肿瘤;干细胞<br>经验分享:还可以,embo j退稿的回收站,到elife 差远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=复旦生科院呵呵, createdTime=Tue Nov 16 08:59:39 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2023-03-13 Linyan Yu 来自山东省

    最近有投这个期刊的老师们,请问一下初审一般要多久啊?

    6

    展开6条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2106904, encodeId=8a7121069042d, content=偏重的研究方向:干细胞<br>经验分享:哈哈,大家都不要投了,2022年最新版中科院分区该杂志已被踢出一区,指挥棒威武霸气!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b4a2455253, createdName=看看叫啥呢, createdTime=Wed Dec 21 10:37:31 CST 2022, time=2022-12-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=563739, encodeId=d8c4563e3997, content=请教EMBO reports文稿提交后多久可以收到提交成功的邮件,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Nov 28 16:43:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166320, encodeId=bc0f216632088, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:有幸中过一篇 虽然IF不高 但是杂志质量很不错的 审稿很严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d566480437, createdName=ms2000001424864644, createdTime=Thu Nov 02 16:59:11 CST 2023, time=2023-11-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119273, encodeId=f2f921192e385, content=最近有投这个期刊的老师们,请问一下初审一般要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Mon Mar 13 22:08:52 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2095960, encodeId=7b3e209596012, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:EMBO reports现任主编是Bernd Pulverer教授,之前是Nature cell biology的主编,杂志偏向于有conceptual advance的文章,从投稿到接收平均8个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue Oct 25 07:07:05 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217211, encodeId=9505121e2110c, content=怎么收不到decision letter,问编辑也不回信,怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14c65506441, createdName=ms7000001136469102, createdTime=Thu May 05 23:18:57 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964782, encodeId=015b964e8253, content=Under Editorial Consideration11th May 21 Manuscript Under Peer Review28th Apr 21 Under Editorial Consideration28th Apr 21 Manuscript Received22nd Apr 21 Manuscript Submitted21st Apr 21 这是最近投稿文章状态,可以参考一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed May 12 06:26:51 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089979, encodeId=14e010899e9b6, content=我能直接投nature/science这种顶级杂志吗?它们会反馈意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089980, encodeId=61d71089980a2, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070657, encodeId=149b10e0657ae, content=偏重的研究方向:肿瘤;干细胞<br>经验分享:还可以,embo j退稿的回收站,到elife 差远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=复旦生科院呵呵, createdTime=Tue Nov 16 08:59:39 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2022-10-25 slientwo

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:肿瘤
    经验分享:EMBO reports现任主编是Bernd Pulverer教授,之前是Nature cell biology的主编,杂志偏向于有conceptual advance的文章,从投稿到接收平均8个月左右。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2106904, encodeId=8a7121069042d, content=偏重的研究方向:干细胞<br>经验分享:哈哈,大家都不要投了,2022年最新版中科院分区该杂志已被踢出一区,指挥棒威武霸气!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b4a2455253, createdName=看看叫啥呢, createdTime=Wed Dec 21 10:37:31 CST 2022, time=2022-12-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=563739, encodeId=d8c4563e3997, content=请教EMBO reports文稿提交后多久可以收到提交成功的邮件,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Nov 28 16:43:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166320, encodeId=bc0f216632088, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:有幸中过一篇 虽然IF不高 但是杂志质量很不错的 审稿很严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d566480437, createdName=ms2000001424864644, createdTime=Thu Nov 02 16:59:11 CST 2023, time=2023-11-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119273, encodeId=f2f921192e385, content=最近有投这个期刊的老师们,请问一下初审一般要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Mon Mar 13 22:08:52 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2095960, encodeId=7b3e209596012, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:EMBO reports现任主编是Bernd Pulverer教授,之前是Nature cell biology的主编,杂志偏向于有conceptual advance的文章,从投稿到接收平均8个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue Oct 25 07:07:05 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217211, encodeId=9505121e2110c, content=怎么收不到decision letter,问编辑也不回信,怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14c65506441, createdName=ms7000001136469102, createdTime=Thu May 05 23:18:57 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964782, encodeId=015b964e8253, content=Under Editorial Consideration11th May 21 Manuscript Under Peer Review28th Apr 21 Under Editorial Consideration28th Apr 21 Manuscript Received22nd Apr 21 Manuscript Submitted21st Apr 21 这是最近投稿文章状态,可以参考一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed May 12 06:26:51 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089979, encodeId=14e010899e9b6, content=我能直接投nature/science这种顶级杂志吗?它们会反馈意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089980, encodeId=61d71089980a2, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070657, encodeId=149b10e0657ae, content=偏重的研究方向:肿瘤;干细胞<br>经验分享:还可以,embo j退稿的回收站,到elife 差远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=复旦生科院呵呵, createdTime=Tue Nov 16 08:59:39 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2022-05-05 ms7000001136469102

    怎么收不到decision letter,问编辑也不回信,怎么办

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2106904, encodeId=8a7121069042d, content=偏重的研究方向:干细胞<br>经验分享:哈哈,大家都不要投了,2022年最新版中科院分区该杂志已被踢出一区,指挥棒威武霸气!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b4a2455253, createdName=看看叫啥呢, createdTime=Wed Dec 21 10:37:31 CST 2022, time=2022-12-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=563739, encodeId=d8c4563e3997, content=请教EMBO reports文稿提交后多久可以收到提交成功的邮件,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Nov 28 16:43:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166320, encodeId=bc0f216632088, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:有幸中过一篇 虽然IF不高 但是杂志质量很不错的 审稿很严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d566480437, createdName=ms2000001424864644, createdTime=Thu Nov 02 16:59:11 CST 2023, time=2023-11-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119273, encodeId=f2f921192e385, content=最近有投这个期刊的老师们,请问一下初审一般要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Mon Mar 13 22:08:52 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2095960, encodeId=7b3e209596012, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:EMBO reports现任主编是Bernd Pulverer教授,之前是Nature cell biology的主编,杂志偏向于有conceptual advance的文章,从投稿到接收平均8个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue Oct 25 07:07:05 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217211, encodeId=9505121e2110c, content=怎么收不到decision letter,问编辑也不回信,怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14c65506441, createdName=ms7000001136469102, createdTime=Thu May 05 23:18:57 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964782, encodeId=015b964e8253, content=Under Editorial Consideration11th May 21 Manuscript Under Peer Review28th Apr 21 Under Editorial Consideration28th Apr 21 Manuscript Received22nd Apr 21 Manuscript Submitted21st Apr 21 这是最近投稿文章状态,可以参考一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed May 12 06:26:51 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089979, encodeId=14e010899e9b6, content=我能直接投nature/science这种顶级杂志吗?它们会反馈意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089980, encodeId=61d71089980a2, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070657, encodeId=149b10e0657ae, content=偏重的研究方向:肿瘤;干细胞<br>经验分享:还可以,embo j退稿的回收站,到elife 差远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=复旦生科院呵呵, createdTime=Tue Nov 16 08:59:39 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2021-05-12 tomsyu

    Under Editorial Consideration11th May 21 Manuscript Under Peer Review28th Apr 21 Under Editorial Consideration28th Apr 21 Manuscript Received22nd Apr 21 Manuscript Submitted21st Apr 21 这是最近投稿文章状态,可以参考一下

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2106904, encodeId=8a7121069042d, content=偏重的研究方向:干细胞<br>经验分享:哈哈,大家都不要投了,2022年最新版中科院分区该杂志已被踢出一区,指挥棒威武霸气!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b4a2455253, createdName=看看叫啥呢, createdTime=Wed Dec 21 10:37:31 CST 2022, time=2022-12-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=563739, encodeId=d8c4563e3997, content=请教EMBO reports文稿提交后多久可以收到提交成功的邮件,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Nov 28 16:43:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166320, encodeId=bc0f216632088, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:有幸中过一篇 虽然IF不高 但是杂志质量很不错的 审稿很严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d566480437, createdName=ms2000001424864644, createdTime=Thu Nov 02 16:59:11 CST 2023, time=2023-11-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119273, encodeId=f2f921192e385, content=最近有投这个期刊的老师们,请问一下初审一般要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Mon Mar 13 22:08:52 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2095960, encodeId=7b3e209596012, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:EMBO reports现任主编是Bernd Pulverer教授,之前是Nature cell biology的主编,杂志偏向于有conceptual advance的文章,从投稿到接收平均8个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue Oct 25 07:07:05 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217211, encodeId=9505121e2110c, content=怎么收不到decision letter,问编辑也不回信,怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14c65506441, createdName=ms7000001136469102, createdTime=Thu May 05 23:18:57 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964782, encodeId=015b964e8253, content=Under Editorial Consideration11th May 21 Manuscript Under Peer Review28th Apr 21 Under Editorial Consideration28th Apr 21 Manuscript Received22nd Apr 21 Manuscript Submitted21st Apr 21 这是最近投稿文章状态,可以参考一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed May 12 06:26:51 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089979, encodeId=14e010899e9b6, content=我能直接投nature/science这种顶级杂志吗?它们会反馈意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089980, encodeId=61d71089980a2, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070657, encodeId=149b10e0657ae, content=偏重的研究方向:肿瘤;干细胞<br>经验分享:还可以,embo j退稿的回收站,到elife 差远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=复旦生科院呵呵, createdTime=Tue Nov 16 08:59:39 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2021-12-29 ms6000000264964247

    我能直接投nature/science这种顶级杂志吗?它们会反馈意见吗?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2106904, encodeId=8a7121069042d, content=偏重的研究方向:干细胞<br>经验分享:哈哈,大家都不要投了,2022年最新版中科院分区该杂志已被踢出一区,指挥棒威武霸气!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b4a2455253, createdName=看看叫啥呢, createdTime=Wed Dec 21 10:37:31 CST 2022, time=2022-12-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=563739, encodeId=d8c4563e3997, content=请教EMBO reports文稿提交后多久可以收到提交成功的邮件,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Nov 28 16:43:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166320, encodeId=bc0f216632088, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:有幸中过一篇 虽然IF不高 但是杂志质量很不错的 审稿很严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d566480437, createdName=ms2000001424864644, createdTime=Thu Nov 02 16:59:11 CST 2023, time=2023-11-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119273, encodeId=f2f921192e385, content=最近有投这个期刊的老师们,请问一下初审一般要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Mon Mar 13 22:08:52 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2095960, encodeId=7b3e209596012, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:EMBO reports现任主编是Bernd Pulverer教授,之前是Nature cell biology的主编,杂志偏向于有conceptual advance的文章,从投稿到接收平均8个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue Oct 25 07:07:05 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217211, encodeId=9505121e2110c, content=怎么收不到decision letter,问编辑也不回信,怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14c65506441, createdName=ms7000001136469102, createdTime=Thu May 05 23:18:57 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964782, encodeId=015b964e8253, content=Under Editorial Consideration11th May 21 Manuscript Under Peer Review28th Apr 21 Under Editorial Consideration28th Apr 21 Manuscript Received22nd Apr 21 Manuscript Submitted21st Apr 21 这是最近投稿文章状态,可以参考一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed May 12 06:26:51 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089979, encodeId=14e010899e9b6, content=我能直接投nature/science这种顶级杂志吗?它们会反馈意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089980, encodeId=61d71089980a2, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070657, encodeId=149b10e0657ae, content=偏重的研究方向:肿瘤;干细胞<br>经验分享:还可以,embo j退稿的回收站,到elife 差远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=复旦生科院呵呵, createdTime=Tue Nov 16 08:59:39 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2021-12-29 ms6000000264964247

    选刊时有哪些需要避免的雷区?

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2106904, encodeId=8a7121069042d, content=偏重的研究方向:干细胞<br>经验分享:哈哈,大家都不要投了,2022年最新版中科院分区该杂志已被踢出一区,指挥棒威武霸气!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b4a2455253, createdName=看看叫啥呢, createdTime=Wed Dec 21 10:37:31 CST 2022, time=2022-12-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=563739, encodeId=d8c4563e3997, content=请教EMBO reports文稿提交后多久可以收到提交成功的邮件,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Nov 28 16:43:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166320, encodeId=bc0f216632088, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:有幸中过一篇 虽然IF不高 但是杂志质量很不错的 审稿很严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d566480437, createdName=ms2000001424864644, createdTime=Thu Nov 02 16:59:11 CST 2023, time=2023-11-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2119273, encodeId=f2f921192e385, content=最近有投这个期刊的老师们,请问一下初审一般要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a55725098, createdName=Linyan Yu, createdTime=Mon Mar 13 22:08:52 CST 2023, time=2023-03-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2095960, encodeId=7b3e209596012, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:EMBO reports现任主编是Bernd Pulverer教授,之前是Nature cell biology的主编,杂志偏向于有conceptual advance的文章,从投稿到接收平均8个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue Oct 25 07:07:05 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217211, encodeId=9505121e2110c, content=怎么收不到decision letter,问编辑也不回信,怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14c65506441, createdName=ms7000001136469102, createdTime=Thu May 05 23:18:57 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964782, encodeId=015b964e8253, content=Under Editorial Consideration11th May 21 Manuscript Under Peer Review28th Apr 21 Under Editorial Consideration28th Apr 21 Manuscript Received22nd Apr 21 Manuscript Submitted21st Apr 21 这是最近投稿文章状态,可以参考一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed May 12 06:26:51 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089979, encodeId=14e010899e9b6, content=我能直接投nature/science这种顶级杂志吗?它们会反馈意见吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089980, encodeId=61d71089980a2, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070657, encodeId=149b10e0657ae, content=偏重的研究方向:肿瘤;干细胞<br>经验分享:还可以,embo j退稿的回收站,到elife 差远了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=复旦生科院呵呵, createdTime=Tue Nov 16 08:59:39 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2021-11-16 复旦生科院呵呵

    偏重的研究方向:肿瘤;干细胞
    经验分享:还可以,embo j退稿的回收站,到elife 差远了

    0

共48条页码: 1/5页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分